

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 100/50mcg | 3 inhalers | NZD256.56 | NZD1,026.20 NZD769.65 Best Price | |
| 100/50mcg | 2 inhalers | NZD265.97 | NZD709.23 NZD531.92 | |
| 100/50mcg | inhaler | NZD317.73 | NZD423.64 NZD317.73 | |
| 250/50mcg | 3 inhalers | NZD276.16 | NZD1,104.66 NZD828.49 | |
| 250/50mcg | 2 inhalers | NZD318.93 | NZD850.45 NZD637.84 | |
| 250/50mcg | inhaler | NZD360.10 | NZD480.13 NZD360.10 | |
| 500/50mcg | 3 inhalers | NZD339.72 | NZD1,358.86 NZD1,019.15 Popular | |
| 500/50mcg | 2 inhalers | NZD371.89 | NZD991.68 NZD743.76 | |
| 500/50mcg | inhaler | NZD402.47 | NZD536.62 NZD402.47 |
Salmeterol + Fluticasone is a combination inhaler used for maintenance in asthma and chronic obstructive pulmonary disease. It blends Salmeterol, a long-acting beta-agonist, with Fluticasone, an inhaled corticosteroid. Together they reduce inflammation and keep airways open. The goal is steadier breathing and fewer flare ups when used consistently as prescribed. It is not a rescue inhaler and should not be used to treat sudden breathlessness without a fast-acting inhaler.
Fluticasone cools swelling inside the airways, lowering the immune response that causes irritation. Salmeterol relaxes the airway muscles, helping to prevent constriction for up to 12 hours. The two medicines support each other: the steroid controls the underlying inflammation, while the LABA keeps the airways wider over time. Regular use can reduce symptoms, improve exercise tolerance, and cut the number of nighttime awakenings from breathing problems.
This medicine is prescribed for people with persistent asthma or COPD who need regular, long‑term control. It is intended for maintenance, not immediate relief. It may be suitable when a single inhaled corticosteroid is not enough and a LABA is added under medical guidance. Do not start or continue therapy if you have a severe infection, a known allergy to the components, or if your symptoms worsen rapidly. Always follow your healthcare provider’s guidance on suitability and duration of treatment.
Use the inhaler exactly as directed. It is usually taken twice daily, at evenly spaced times. Prime the device if required and shake gently if the instructions say so. Breathe out fully, place the mouthpiece in your mouth, and inhale slowly and deeply. Hold your breath for several seconds, then exhale. Rinse your mouth with water after each use to help prevent throat irritation and oral thrush. Do not share your inhaler and keep it away from moisture and heat. If you miss a dose, resume as directed by your clinician and do not double up.
Common effects include throat irritation, hoarseness, coughing, and headaches. Some people notice a slight feeling of increased heart rate or tremor after inhalation. Mouth or throat infections can occur if you do not rinse after use. Less frequent but serious reactions include signs of an allergic response, severe wheezing, or swelling of the face and throat. If you have a viral infection or symptoms like chest pain, seek medical advice promptly. Pregnant or nursing individuals should discuss risks and benefits with a doctor. The combination should be used with care in people with certain heart, eye, or metabolic conditions.
Check your prescription details for dosing and device type, as different markets offer variations. Confirm that you are using it for maintenance, not relief. Ask about possible interactions with other medicines, including over‑the‑counter products and supplements. Practice good inhalation technique and consider a spacer if recommended. Store the inhaler at room temperature and monitor expiry dates. If you notice no improvement after several weeks or experience persistent side effects, contact your clinician to review the plan.
14–21 days. Free from NZD339.16 .
5–9 days. NZD50.87
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.